SLC6A6 Human (+)-pilocarpine increases expression ISO Slc6a6 (Mus musculus) 6480464 Pilocarpine results in increased expression of SLC6A6 mRNA CTD PMID:21219332 SLC6A6 Human (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC6A6 mRNA CTD PMID:22079256 SLC6A6 Human 1-benzylpiperazine increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 N-benzylpiperazine results in increased expression of SLC6A6 mRNA CTD PMID:26821219 SLC6A6 Human 17alpha-ethynylestradiol affects expression ISO Slc6a6 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of SLC6A6 mRNA CTD PMID:17555576 SLC6A6 Human 17alpha-ethynylestradiol affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Ethinyl Estradiol affects the expression of SLC6A6 mRNA CTD PMID:26865667 SLC6A6 Human 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC6A6 mRNA CTD PMID:26865667 SLC6A6 Human 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SLC6A6 mRNA CTD PMID:18936297 SLC6A6 Human 17alpha-ethynylestradiol multiple interactions ISO Slc6a6 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SLC6A6 mRNA CTD PMID:17942748 SLC6A6 Human 17alpha-ethynylestradiol decreases expression ISO Slc6a6 (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of SLC6A6 mRNA CTD PMID:17942748 SLC6A6 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of SLC6A6 mRNA and Estradiol promotes the reaction [ESR2 protein affects the expression of SLC6A6 mRNA] CTD PMID:19619570 and PMID:20404318 SLC6A6 Human 17beta-estradiol multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A6 mRNA CTD PMID:32741896 SLC6A6 Human 17beta-estradiol affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Estradiol affects the expression of SLC6A6 mRNA CTD PMID:32145629 SLC6A6 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC6A6 mRNA CTD PMID:15223131 more ... SLC6A6 Human 17beta-estradiol 3-benzoate multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A6 mRNA CTD PMID:32741896 SLC6A6 Human 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [3 more ... CTD PMID:16984957 SLC6A6 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:38568856 SLC6A6 Human 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Slc6a6 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of SLC6A6 mRNA CTD PMID:19619570 SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A6 mRNA CTD PMID:19619570 more ... SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc6a6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A6 mRNA CTD PMID:21570461 SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc6a6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A6 mRNA CTD PMID:15328365 more ... SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC6A6 mRNA CTD PMID:21215274 and PMID:34747641 SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A6 mRNA CTD PMID:22298810 SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A6 mRNA CTD PMID:16984957 more ... SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc6a6 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A6 mRNA CTD PMID:16984957 SLC6A6 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc6a6 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SLC6A6 mRNA more ... CTD PMID:16984957 more ... SLC6A6 Human 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Slc6a6 (Mus musculus) 6480464 2 more ... CTD PMID:25768209 SLC6A6 Human 2,4-dinitrotoluene affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of SLC6A6 mRNA CTD PMID:21346803 SLC6A6 Human 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [3 more ... CTD PMID:16984957 SLC6A6 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 3 more ... CTD PMID:16984957 more ... SLC6A6 Human 3,3',5,5'-tetrabromobisphenol A increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 tetrabromobisphenol A results in increased expression of SLC6A6 mRNA CTD PMID:28300664 SLC6A6 Human 3,4-methylenedioxymethamphetamine decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of SLC6A6 mRNA CTD PMID:30071829 SLC6A6 Human 3-chloropropane-1,2-diol increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of SLC6A6 protein CTD PMID:34915118 SLC6A6 Human 4,4'-diaminodiphenylmethane increases expression ISO Slc6a6 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of SLC6A6 mRNA CTD PMID:18648102 SLC6A6 Human 4,4'-sulfonyldiphenol decreases methylation EXP 6480464 bisphenol S results in decreased methylation of SLC6A6 gene CTD PMID:31601247 SLC6A6 Human 4-hydroxyphenyl retinamide increases expression ISO Slc6a6 (Mus musculus) 6480464 Fenretinide results in increased expression of SLC6A6 mRNA CTD PMID:28973697 SLC6A6 Human 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Omeprazole affects the expression of SLC6A6 mRNA CTD PMID:19483382 SLC6A6 Human 6-propyl-2-thiouracil affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Propylthiouracil affects the expression of SLC6A6 mRNA CTD PMID:19483382 SLC6A6 Human 6-propyl-2-thiouracil increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of SLC6A6 mRNA CTD PMID:24780913 SLC6A6 Human acetamide increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 acetamide results in increased expression of SLC6A6 mRNA CTD PMID:31881176 SLC6A6 Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC6A6 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC6A6 mRNA CTD PMID:32699268 SLC6A6 Human acrylamide decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of SLC6A6 mRNA CTD PMID:28959563 SLC6A6 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of SLC6A6 protein CTD PMID:20106945 SLC6A6 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SLC6A6 mRNA CTD PMID:32234424 SLC6A6 Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of SLC6A6 intron CTD PMID:30157460 SLC6A6 Human aflatoxin B1 decreases expression ISO Slc6a6 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of SLC6A6 mRNA CTD PMID:19770486 SLC6A6 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of SLC6A6 mRNA CTD PMID:23830798 and PMID:33167477 SLC6A6 Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC6A6 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC6A6 mRNA CTD PMID:32699268 SLC6A6 Human alpha-Zearalanol multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC6A6 mRNA CTD PMID:35163327 SLC6A6 Human amiodarone affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Amiodarone affects the expression of SLC6A6 mRNA CTD PMID:18355885 and PMID:19483382 SLC6A6 Human amitriptyline affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Amitriptyline affects the expression of SLC6A6 mRNA CTD PMID:18355885 SLC6A6 Human amitrole increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Amitrole results in increased expression of SLC6A6 mRNA CTD PMID:30047161 SLC6A6 Human ammonium chloride affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of SLC6A6 mRNA CTD PMID:16483693 SLC6A6 Human amphotericin B decreases expression EXP 6480464 Amphotericin B analog results in decreased expression of SLC6A6 mRNA CTD PMID:28534445 SLC6A6 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of SLC6A6 mRNA CTD PMID:33212167 SLC6A6 Human arsane affects expression EXP 6480464 Arsenic affects the expression of SLC6A6 mRNA CTD PMID:18414638 SLC6A6 Human arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A6 mRNA CTD PMID:32525701 SLC6A6 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of SLC6A6 gene CTD PMID:25304211 SLC6A6 Human arsenic atom affects expression EXP 6480464 Arsenic affects the expression of SLC6A6 mRNA CTD PMID:18414638 SLC6A6 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of SLC6A6 gene CTD PMID:25304211 SLC6A6 Human arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A6 mRNA CTD PMID:32525701 SLC6A6 Human atrazine affects methylation ISO Slc6a6 (Rattus norvegicus) 6480464 Atrazine affects the methylation of SLC6A6 gene CTD PMID:28931070 SLC6A6 Human atrazine decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Atrazine results in decreased expression of SLC6A6 mRNA CTD PMID:36841081 SLC6A6 Human avobenzone increases expression EXP 6480464 avobenzone results in increased expression of SLC6A6 mRNA CTD PMID:31016361 SLC6A6 Human azathioprine increases expression EXP 6480464 Azathioprine results in increased expression of SLC6A6 mRNA CTD PMID:22623647 SLC6A6 Human benzbromarone affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Benzbromarone affects the expression of SLC6A6 mRNA CTD PMID:19483382 SLC6A6 Human benzo[a]pyrene decreases expression ISO Slc6a6 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLC6A6 mRNA CTD PMID:19770486 SLC6A6 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of SLC6A6 5' UTR CTD PMID:27901495 SLC6A6 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of SLC6A6 3' UTR and Benzo(a)pyrene affects the methylation of SLC6A6 promoter CTD PMID:27901495 SLC6A6 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of SLC6A6 mRNA CTD PMID:20106945 more ... SLC6A6 Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 SLC6A6 Human benzo[a]pyrene diol epoxide I increases expression EXP 6480464 7 more ... CTD PMID:20382639 SLC6A6 Human beta-lapachone decreases expression EXP 6480464 beta-lapachone results in decreased expression of SLC6A6 mRNA CTD PMID:38218311 SLC6A6 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of SLC6A6 mRNA CTD PMID:38218311 SLC6A6 Human beta-naphthoflavone multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC6A6 mRNA CTD PMID:18164116 SLC6A6 Human bexarotene increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 bexarotene results in increased expression of SLC6A6 mRNA CTD PMID:16648578 SLC6A6 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC6A6 mRNA CTD PMID:23019147 and PMID:29275510 SLC6A6 Human bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of SLC6A6 gene CTD PMID:31601247 SLC6A6 Human bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC6A6 gene CTD PMID:31601247 SLC6A6 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC6A6 protein CTD PMID:33376534 SLC6A6 Human bisphenol A affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 bisphenol A affects the expression of SLC6A6 mRNA CTD PMID:32145629 SLC6A6 Human bisphenol A increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SLC6A6 mRNA CTD PMID:30816183 more ... SLC6A6 Human bisphenol F increases expression ISO Slc6a6 (Mus musculus) 6480464 bisphenol F results in increased expression of SLC6A6 mRNA CTD PMID:38685157 SLC6A6 Human bisphenol F multiple interactions EXP 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of SLC6A6 gene CTD PMID:31601247 SLC6A6 Human bromobenzene increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 bromobenzene results in increased expression of SLC6A6 mRNA CTD PMID:32479839 SLC6A6 Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of SLC6A6 mRNA CTD PMID:26079696 SLC6A6 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC6A6 mRNA CTD PMID:29741670 SLC6A6 Human cadmium dichloride increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of SLC6A6 mRNA CTD PMID:33453195 SLC6A6 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC6A6 mRNA CTD PMID:29741670 SLC6A6 Human cadmium dichloride decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Cadmium Chloride results in decreased expression of SLC6A6 mRNA CTD PMID:25993096 SLC6A6 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLC6A6 mRNA CTD PMID:25596134 SLC6A6 Human cadmium sulfate multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of SLC6A6 mRNA CTD PMID:18654764 SLC6A6 Human carbon nanotube decreases expression ISO Slc6a6 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of SLC6A6 mRNA CTD PMID:25554681 and PMID:25620056 SLC6A6 Human chlordecone increases expression ISO Slc6a6 (Mus musculus) 6480464 Chlordecone results in increased expression of SLC6A6 mRNA CTD PMID:33711761 SLC6A6 Human chloroacetaldehyde affects expression EXP 6480464 chloroacetaldehyde affects the expression of SLC6A6 mRNA CTD PMID:25596134 SLC6A6 Human chloroprene increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Chloroprene results in increased expression of SLC6A6 mRNA CTD PMID:23125180 SLC6A6 Human chlorpromazine increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Chlorpromazine results in increased expression of SLC6A6 mRNA CTD PMID:25596134 SLC6A6 Human cidofovir anhydrous affects expression EXP 6480464 Cidofovir affects the expression of SLC6A6 mRNA CTD PMID:25596134 SLC6A6 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of SLC6A6 mRNA CTD PMID:27594783 SLC6A6 Human cisplatin decreases response to substance ISO Slc6a6 (Mus musculus) 6480464 SLC6A6 protein results in decreased susceptibility to Cisplatin CTD PMID:21220912 SLC6A6 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SLC6A6 mRNA CTD PMID:27392435 SLC6A6 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC6A6 mRNA CTD PMID:27392435 SLC6A6 Human clofibrate affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Clofibrate affects the expression of SLC6A6 mRNA CTD PMID:19483382 SLC6A6 Human clomipramine affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Clomipramine affects the expression of SLC6A6 mRNA CTD PMID:18355885 SLC6A6 Human cobalt dichloride multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of SLC6A6 mRNA CTD PMID:18654764 SLC6A6 Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of SLC6A6 mRNA CTD PMID:38568856 SLC6A6 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of SLC6A6 mRNA CTD PMID:19549813 SLC6A6 Human crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of SLC6A6 mRNA CTD PMID:25351596 SLC6A6 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of SLC6A6 mRNA CTD PMID:25596134 SLC6A6 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SLC6A6 mRNA CTD PMID:20106945 and PMID:25562108 SLC6A6 Human DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC6A6 mRNA CTD PMID:38568856 SLC6A6 Human decabromodiphenyl ether decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 decabromobiphenyl ether results in decreased expression of SLC6A6 mRNA CTD PMID:23640034 SLC6A6 Human dextran sulfate multiple interactions ISO Slc6a6 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A6 mRNA CTD PMID:29950665 SLC6A6 Human diallyl disulfide increases expression EXP 6480464 diallyl disulfide results in increased expression of SLC6A6 mRNA CTD PMID:34887701 SLC6A6 Human diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of SLC6A6 mRNA CTD PMID:34887701 SLC6A6 Human Diallyltetrasulfane increases expression EXP 6480464 diallyl tetrasulfide results in increased expression of SLC6A6 mRNA CTD PMID:34887701 SLC6A6 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of SLC6A6 mRNA CTD PMID:37042841 SLC6A6 Human dibutyl phthalate increases expression ISO Slc6a6 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of SLC6A6 mRNA CTD PMID:21266533 SLC6A6 Human dibutyl phthalate decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in decreased expression of SLC6A6 mRNA CTD PMID:21266533 SLC6A6 Human diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SLC6A6 mRNA CTD PMID:19371625 SLC6A6 Human dimethylarsinic acid increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Cacodylic Acid results in increased expression of SLC6A6 mRNA CTD PMID:17720352 SLC6A6 Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of SLC6A6 mRNA CTD PMID:25596134 and PMID:26516004 SLC6A6 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC6A6 mRNA CTD PMID:27188386 SLC6A6 Human doxorubicin decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Doxorubicin results in decreased expression of SLC6A6 mRNA CTD PMID:17105721 SLC6A6 Human endosulfan increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of SLC6A6 mRNA CTD PMID:29391264 SLC6A6 Human fenthion increases expression ISO Slc6a6 (Mus musculus) 6480464 Fenthion results in increased expression of SLC6A6 mRNA CTD PMID:34813904 SLC6A6 Human fulvestrant increases methylation EXP 6480464 Fulvestrant results in increased methylation of SLC6A6 gene CTD PMID:31601247 SLC6A6 Human fulvestrant multiple interactions EXP 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC6A6 gene and [bisphenol F co-treated with Fulvestrant] results in increased methylation of SLC6A6 gene CTD PMID:31601247 SLC6A6 Human genistein increases expression EXP 6480464 Genistein results in increased expression of SLC6A6 mRNA CTD PMID:19371625 and PMID:23019147 SLC6A6 Human genistein affects expression EXP 6480464 Genistein affects the expression of SLC6A6 mRNA CTD PMID:26865667 SLC6A6 Human gentamycin decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of SLC6A6 mRNA CTD PMID:33387578 SLC6A6 Human glycidyl methacrylate decreases expression EXP 6480464 glycidyl methacrylate results in decreased expression of SLC6A6 protein CTD PMID:36641056 SLC6A6 Human imipramine affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Imipramine affects the expression of SLC6A6 mRNA CTD PMID:18355885 SLC6A6 Human indole-3-methanol affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 indole-3-carbinol affects the expression of SLC6A6 mRNA CTD PMID:21396975 SLC6A6 Human indole-3-methanol multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA CTD PMID:22129741 SLC6A6 Human ketoconazole affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Ketoconazole affects the expression of SLC6A6 mRNA CTD PMID:18355885 SLC6A6 Human L-ethionine affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Ethionine affects the expression of SLC6A6 mRNA CTD PMID:19483382 SLC6A6 Human lead diacetate decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 lead acetate results in decreased expression of SLC6A6 mRNA CTD PMID:11578147 SLC6A6 Human lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC6A6 mRNA CTD PMID:38568856 SLC6A6 Human lead(II) chloride multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of SLC6A6 mRNA CTD PMID:18654764 SLC6A6 Human manganese atom increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Manganese results in increased expression of SLC6A6 mRNA CTD PMID:20832424 SLC6A6 Human manganese(0) increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Manganese results in increased expression of SLC6A6 mRNA CTD PMID:20832424 SLC6A6 Human metformin increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Metformin results in increased expression of SLC6A6 mRNA CTD PMID:25596134 SLC6A6 Human methidathion increases expression ISO Slc6a6 (Mus musculus) 6480464 methidathion results in increased expression of SLC6A6 mRNA CTD PMID:34813904 SLC6A6 Human methimazole increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Methimazole results in increased expression of SLC6A6 mRNA CTD PMID:30047161 SLC6A6 Human N-acetyl-L-cysteine multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA CTD PMID:22129741 SLC6A6 Human N-methyl-4-phenylpyridinium decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC6A6 mRNA CTD PMID:28801915 SLC6A6 Human N-nitrosodiethylamine multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SLC6A6 mRNA and [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of SLC6A6 mRNA CTD PMID:18164116 and PMID:22129741 SLC6A6 Human N-Nitrosopyrrolidine increases expression EXP 6480464 N-Nitrosopyrrolidine results in increased expression of SLC6A6 mRNA CTD PMID:32234424 SLC6A6 Human nefazodone decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 nefazodone results in decreased expression of SLC6A6 mRNA CTD PMID:24136188 SLC6A6 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of SLC6A6 mRNA CTD PMID:24768652 and PMID:25583101 SLC6A6 Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of SLC6A6 mRNA CTD PMID:22714537 SLC6A6 Human O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of SLC6A6 mRNA CTD PMID:32234424 SLC6A6 Human omeprazole affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Omeprazole affects the expression of SLC6A6 mRNA CTD PMID:19483382 SLC6A6 Human oxaliplatin multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC6A6 mRNA CTD PMID:25729387 SLC6A6 Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC6A6 mRNA more ... CTD PMID:32699268 and PMID:35430440 SLC6A6 Human p-toluidine decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 4-toluidine results in decreased expression of SLC6A6 mRNA CTD PMID:27638505 SLC6A6 Human paracetamol decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of SLC6A6 mRNA CTD PMID:17202762 more ... SLC6A6 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC6A6 mRNA CTD PMID:29067470 SLC6A6 Human paracetamol affects expression ISO Slc6a6 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC6A6 mRNA CTD PMID:17562736 SLC6A6 Human parathion increases expression ISO Slc6a6 (Mus musculus) 6480464 Parathion results in increased expression of SLC6A6 mRNA CTD PMID:34813904 SLC6A6 Human pentachlorophenol increases expression ISO Slc6a6 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of SLC6A6 mRNA CTD PMID:23892564 SLC6A6 Human perfluorooctane-1-sulfonic acid decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC6A6 mRNA CTD PMID:19162173 SLC6A6 Human perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of SLC6A6 mRNA CTD PMID:36864359 SLC6A6 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Slc6a6 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC6A6 mRNA CTD PMID:36331819 SLC6A6 Human perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC6A6 mRNA CTD PMID:32790152 SLC6A6 Human perfluorooctanoic acid decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in decreased expression of SLC6A6 mRNA CTD PMID:19162173 SLC6A6 Human perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SLC6A6 mRNA CTD PMID:36326898 SLC6A6 Human perfluorooctanoic acid multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC6A6 mRNA CTD PMID:35163327 SLC6A6 Human phenformin increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Phenformin results in increased expression of SLC6A6 mRNA CTD PMID:31324951 SLC6A6 Human phenobarbital affects expression ISO Slc6a6 (Mus musculus) 6480464 Phenobarbital affects the expression of SLC6A6 mRNA CTD PMID:23091169 SLC6A6 Human pirinixic acid affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 pirinixic acid affects the expression of SLC6A6 mRNA CTD PMID:19483382 SLC6A6 Human pirinixic acid decreases expression ISO Slc6a6 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC6A6 mRNA CTD PMID:23811191 SLC6A6 Human pirinixic acid decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 pirinixic acid results in decreased expression of SLC6A6 mRNA CTD PMID:19162173 SLC6A6 Human potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of SLC6A6 mRNA CTD PMID:22079256 SLC6A6 Human potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC6A6 mRNA CTD PMID:22079256 SLC6A6 Human pregnenolone 16alpha-carbonitrile decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC6A6 mRNA CTD PMID:19162173 SLC6A6 Human pregnenolone 16alpha-carbonitrile decreases expression ISO Slc6a6 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC6A6 mRNA CTD PMID:28903501 SLC6A6 Human resveratrol multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of SLC6A6 mRNA CTD PMID:25905778 SLC6A6 Human rotenone increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Rotenone results in increased expression of SLC6A6 mRNA CTD PMID:19013527 SLC6A6 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC6A6 mRNA CTD PMID:27188386 SLC6A6 Human serpentine asbestos decreases expression EXP 6480464 Asbestos and Serpentine results in decreased expression of SLC6A6 mRNA CTD PMID:21148743 SLC6A6 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of SLC6A6 mRNA and Silicon Dioxide results in increased expression of SLC6A6 mRNA CTD PMID:25351596 and PMID:25895662 SLC6A6 Human sodium arsenate increases expression ISO Slc6a6 (Mus musculus) 6480464 sodium arsenate results in increased expression of SLC6A6 mRNA CTD PMID:21795629 SLC6A6 Human sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A6 mRNA CTD PMID:32525701 SLC6A6 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of SLC6A6 mRNA CTD PMID:21281968 more ... SLC6A6 Human sodium arsenite decreases expression ISO Slc6a6 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC6A6 mRNA CTD PMID:37682722 SLC6A6 Human sodium dichromate decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 sodium bichromate results in decreased expression of SLC6A6 mRNA CTD PMID:25993096 SLC6A6 Human streptozocin multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of SLC6A6 mRNA CTD PMID:25905778 SLC6A6 Human sulfadimethoxine increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Sulfadimethoxine results in increased expression of SLC6A6 mRNA CTD PMID:30047161 SLC6A6 Human sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of SLC6A6 mRNA CTD PMID:31838189 SLC6A6 Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of SLC6A6 mRNA CTD PMID:31533062 SLC6A6 Human tamoxifen affects expression ISO Slc6a6 (Mus musculus) 6480464 Tamoxifen affects the expression of SLC6A6 mRNA CTD PMID:17555576 SLC6A6 Human taurine increases expression ISO Slc6a6 (Mus musculus) 6480464 Taurine results in increased expression of SLC6A6 protein CTD PMID:32017914 SLC6A6 Human temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of SLC6A6 mRNA CTD PMID:31758290 SLC6A6 Human testosterone multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLC6A6 mRNA CTD PMID:32741896 SLC6A6 Human tetrachloromethane decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of SLC6A6 protein CTD PMID:17544377 SLC6A6 Human tetrachloromethane increases expression ISO Slc6a6 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC6A6 mRNA and Carbon Tetrachloride results in increased expression of SLC6A6 protein CTD PMID:36310519 SLC6A6 Human tetrachloromethane decreases expression ISO Slc6a6 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC6A6 mRNA CTD PMID:31919559 SLC6A6 Human thioacetamide affects expression ISO Slc6a6 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of SLC6A6 mRNA CTD PMID:19483382 SLC6A6 Human thioacetamide increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of SLC6A6 mRNA CTD PMID:34492290 SLC6A6 Human thioacetamide decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of SLC6A6 mRNA CTD PMID:23411599 SLC6A6 Human titanium dioxide multiple interactions ISO Slc6a6 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A6 mRNA CTD PMID:29950665 SLC6A6 Human topiramate decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 topiramate results in decreased expression of SLC6A6 mRNA CTD PMID:16979414 SLC6A6 Human topotecan multiple interactions ISO Slc6a6 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SLC6A6 mRNA CTD PMID:25729387 SLC6A6 Human topotecan increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Topotecan results in increased expression of SLC6A6 mRNA CTD PMID:25729387 SLC6A6 Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of SLC6A6 mRNA CTD PMID:24935251 and PMID:26272509 SLC6A6 Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC6A6 mRNA CTD PMID:27188386 SLC6A6 Human triphenyl phosphate decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 triphenyl phosphate results in decreased expression of SLC6A6 mRNA CTD PMID:30589522 SLC6A6 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of SLC6A6 mRNA CTD PMID:37042841 SLC6A6 Human triptonide affects expression ISO Slc6a6 (Mus musculus) 6480464 triptonide affects the expression of SLC6A6 mRNA CTD PMID:33045310 SLC6A6 Human valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of SLC6A6 gene CTD PMID:29154799 SLC6A6 Human valproic acid affects splicing ISO Slc6a6 (Rattus norvegicus) 6480464 Valproic Acid affects the splicing of SLC6A6 mRNA CTD PMID:29427782 SLC6A6 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SLC6A6 mRNA CTD PMID:24383497 and PMID:24935251 SLC6A6 Human venlafaxine hydrochloride increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 Venlafaxine Hydrochloride results in increased expression of SLC6A6 mRNA CTD PMID:25423262 SLC6A6 Human vinclozolin decreases expression ISO Slc6a6 (Rattus norvegicus) 6480464 vinclozolin results in decreased expression of SLC6A6 mRNA CTD PMID:23034163 SLC6A6 Human vinclozolin increases expression ISO Slc6a6 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of SLC6A6 mRNA CTD PMID:23034163 SLC6A6 Human vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of SLC6A6 mRNA CTD PMID:27188386 SLC6A6 Human zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of SLC6A6 mRNA CTD PMID:19371625
